Literature DB >> 2580904

Increased phosphatidylinositol metabolism is an important but not an obligatory early event in B lymphocyte activation.

S A Grupp, J A Harmony.   

Abstract

The phosphatidylinositol (PI) response has been implicated in membrane signaling and cell activation. The role of phospholipid metabolism among the early events in B cell activation has not been clear. We have treated murine B cells with anti-Ig antibody and lipopolysaccharide (LPS) and have found that, although anti-IgM induces the PI response, LPS does not. The increase in metabolic labeling of PI is specific to PI, and not the phosphatidylinositols. Anti-IgM unresponsive B cells from CBA/N mice, which may correspond to a specific functional subpopulation of normal B cells, do not increase PI metabolism in response to anti-IgM, nor do they undergo blastogenesis or DNA synthesis. Moreover, when these deficient B cells are given a stimulus sufficient to drive them into S (LPS + anti-IgM), there is still no corresponding activation of PI metabolism. These results are consistent with a two-signal model of xid B cell activation by anti-IgM. One very early signal primes the cells but does not induce the PI response. A second early signal is supplied by LPS. This signal sustains cells in the activated state, allowing them to receive yet other signals to proceed through G1 and progress further along the cell cycle. A similar sequence of events may occur in the normal B cell, with the first signal provided by priming with anti-IgM, and the second signal, the PI response, supported by a sufficiently high dose of anti-IgM to induce PI turnover and maintain the cell in G1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580904

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Roles of protein kinase C and G proteins in activation of murine resting B lymphocytes by endotoxin-associated protein.

Authors:  J R Bandekar; R Castagna; B M Sultzer
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling.

Authors:  Y Yamanashi; Y Fukui; B Wongsasant; Y Kinoshita; Y Ichimori; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

3.  Increase in the intracellular free calcium concentration is not an obligatory early event in lipopeptide-induced B-cell activation.

Authors:  S Hauschildt; A Lückhoff; J Langhorne; K H Wiesmüller; G Jung; W Bessler; J C Cambier
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

4.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

Review 5.  An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes.

Authors:  S L King
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

6.  Mitogenic response of murine B lymphocytes to Salmonella typhimurium lipopolysaccharide requires protein kinase C-dependent late tyrosine phosphorylations.

Authors:  A Mey; J P Revillard
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells.

Authors:  J Mizuguchi; M A Beaven; J H Li; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  B-lymphocyte activation mediated by anti-immunoglobulin antibody in the absence of protein kinase C.

Authors:  J J Mond; N Feuerstein; F D Finkelman; F Huang; K P Huang; G Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Differential responses of p56lyn and p53lyn, products of alternatively spliced lyn mRNA, on stimulation of B-cell antigen receptor.

Authors:  Y Yamanashi; M Miyasaka; M Takeuchi; D Ilic; J Mizuguchi; T Yamamoto
Journal:  Cell Regul       Date:  1991-12

10.  Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome.

Authors:  H U Simon; G B Mills; S Hashimoto; K A Siminovitch
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.